Funding Alert Vol. 28 No. 8 Alert # 4 - August 22, 2017

Texas Department of State Health Services icon Funding Information Center icon Toll free: 1-888-963-7111 ext. 7684 icon Austin phone: (512) 776-7684 icon Fax: (512) 776-7683


The Texas Department of State Health Services Funding Alert is published weekly.  If you wish to subscribe to the Funding Information Center Funding Alert and other services, please call (512) 776-7684 or fill out our online subscription form which can be found at: https://dshs.texas.gov/fic/subscribe.aspx.  Information in the Funding Alert is not copyrighted and may be reproduced. The Texas Department of State Health Services Funding Information Center would appreciate credit for the material used and a copy of the reprint. For information on viewing Adobe Acrobat .pdf and other files, see file viewing information.

Disclaimer: External links to other sites are intended to be informational and do not have the endorsement of the Department of State Health Services. These sites may also not be accessible to persons with disabilities. External e-mail links are provided to you as a courtesy. Please be advised that you are not e-mailing the Texas Department of State Health Services (DSHS) and DSHS policies do not apply should you choose to correspond.


Funding News and Grant Tips

Deadline Fast Approaching - Potential Eligible EMS Providers Wanted for FY 2018 EMS Allotment Allocation Funding
The Texas Department of State Health Services (DSHS) Office of EMS/Trauma Systems Coordination (OEMS/TS) is updating the list of potential eligible emergency medical service (EMS) providers for the FY 18 EMS Allotment/Allocation (also referred as EMS/County Fund). 
This funding consists of EMS and Trauma Care System Account (911 funds), the Emergency Medical Services, Trauma Facilities, and Trauma Care System Fund (1131 funds) and the Designated Trauma Facility and Emergency Medical Services Fund (3588 funds). Funds are distributed through your Regional Advisory Council office.
* If you are a Texas licensed EMS Provider providing 911 and/or emergency transfer service you may be eligible for funding through the EMS Allotment/Allocation fund through the EMS Allotment/Allocation fund (also referred to as EMS/County fund).
* If you are a Texas licensed EMS Provider contracted to provide emergency medical services outside your county of licensure, you have until August 31, 2017 to submit a copy of your contract or letter of agreement.
* Please check the Excel sheet at http://dshs.texas.gov/emstraumasystems/sb102elig.shtm for your organization’s name and contract status. 
If you should have any questions contact Haramain Shaikh, email: Haramain.shaikh@dshs.texas.gov, (512) 834-6700 ext. 2372 or Indra Hernandez, email: Indra.Hernandez@dshs.texas.gov, (512) 834-6669.
From DSHS Office of EMS/Trauma Systems Coordination email, 8/3/17icon

New Draft HIV Service Category Standards - Emergency Financial Assistance (EFA), Home Health Services, Health Education and Risk Reduction (HE/RR), and Rehabilitation Services
The Texas Department of State Health Services (DSHS) HIV Care Services Group is revising the Standards of Care for the Health Resources and Services Administration (HRSA) Ryan White HIV/AIDS Program (RWHAP) service categories. This process includes collaboration with Administrative Agencies receiving Ryan White Part B/State Service Funds and Ryan White Part A Grantees and Part A Planning Councils. The purpose of these standards is to ensure that quality care and services are being provided to all persons living with HIV/AIDS (PLWH) in Texas.
The final draft has been written for the following service categories:
* Emergency Financial Assistance (EFA) - Draft Standards | Administrative Agency Comments.
* Home Health Services - Draft Standards | Administrative Agency Comments.
* Health Education and Risk Reduction (HE/RR) - Draft Standards | Administrative Agency Comments.
* Rehabilitation Services - Draft Standards | Administrative Agency Comments.
As part of this process, DSHS asks providers, consumers, and interested stakeholders to review these documents and provide comments. We value your opinion and hope that you will take the time to review and give feedback. Please comment using the Comments on Service Standard template and submit to Juanita.Salinas@dshs.texas.gov. Public comment will be accepted until September 12, 2017. Comment responses will be posted to the draft standards page.
To see these go to http://www.dshs.texas.gov/hivstd/news/default.shtm
From DSHS HIV/STD Program HIV-STD Insider email, 8/11/17icon

NIH Announces Changes That May Affect Research Involving Human Subjects
If you are conducting NIH-funded research that involves human subjects, or are considering applying to NIH for support of such research, we want to call your attention to important changes that may affect how you:
* select the right NIH funding opportunity announcement;
* write the research strategy and human subjects sections of your application;
* and comply with appropriate policies and regulations.
First, familiarize yourself with the new PHS Human Subject and Clinical Trial Information form. For application due dates of January 25, 2018, and beyond, you will be required to use an updated application forms package (FORMS-E), which includes the new human subject and clinical trial form. This form requests human subject and clinical trials information at the study level using discrete form fields, which is a change from current practice. Contract proposals will also require this information. Learn about the new form here. 
Second, take a moment to answer these four questions about your current or proposed research:
1) Does the study involve human participants? 
2) Are the participants prospectively assigned to an intervention? 
3) Is the study designed to evaluate the effect of the intervention on the participants? 
4) Is the effect that will be evaluated a health-related biomedical or behavioral outcome?
If the answer to all four questions is yes, then your proposed research meets the NIH definition of a clinical trial. Clarified and broadened in 2014, the definition encompasses a wide range of trial types: mechanistic, exploratory/developmental, pilot/feasibility, behavioral, and more. NIH expanded the clinical trial definition in response to widespread calls from diverse stakeholders for improved reporting of research milestones and outcomes, and for assuring maximal transparency. 
Need help determining whether your study would be considered by NIH to be a clinical trial? See our webpage on the definition that includes case studies, FAQs and other resources that can help. Still unsure? Contact your NIH program official or the scientific point of contact listed on the funding opportunity announcement to which you are applying. 
Third, familiarize yourself with NIH policy changes related to enhancing stewardship of clinical trials. 
NIH made a number of policy changes to improve the stewardship of clinical trials across the life cycle of the trial. We encourage you to familiarize yourself with all that is changing, including: 
* The requirement to apply to an FOA that specifically allows for the submission of clinical trial applications for due dates beginning January 25, 2018. 
* Good Clinical Practice training expectations for NIH staff, grantees, and contractors that went into effect January 2017.
* Updated peer review criteria that will be included in FOAs for clinical trial applications and solicitations for due dates on/after January 25, 2018.
* New Human Subject Information form requirements for clinical trials that will be included in updated application forms (FORMS-E) for due dates on/after January 25, 2018, and contract solicitations published as of January 25, 2018.
* Use of a single IRB for non-exempt, multi-site clinical trials for application due dates on/after January 25, 2018. 
* Expanded ClinicalTrials.gov registration and reporting to include all NIH supported clinical trials.
Improving the design, efficiency, and transparency of clinical trials is important because it: 
* respects our ethical obligation to participants to maximize the use of the knowledge from the trials in which they participate;
* facilitates design of clinical trials while reducing unnecessary duplication; 
* promotes broad, timely, and responsible dissemination of research information and results;
* and fosters responsible stewardship of the public’s investment in biomedical research.
The NIH has developed a new Clinical Trial Requirements for NIH Grantees and Contractors web page to bring together all the information you need to know. Please review this information carefully. Your attention to detail will be critical to ensuring successful funding of your clinical trial awards. 
From NIH email, 8/11/17icon


Public Funding Opportunities

Behavioral Health Integration Initiative: HHS-2017-IHS-BH2I-0001
SOURCE: U.S. Department of Health and Human Services, Indian Health Service
APPLICATION DEADLINE: 9/16/17.
$ AVAILABLE: $6 million for 12 awards.
ELIGIBILITY: Please see URL for complete eligibility requirements. 
PURPOSE: The purpose of the Behavioral Health Integration Initiative (BH2I) grant opportunity is to improve the physical and mental health status of people with behavioral health issues by developing an integrative, coordinated system of care between behavioral health and primary care providers.
CFDA: 93.933
CONTACT: Paul Gettys, (301) 443-2114. For more information see https://www.grants.gov/web/grants/view-opportunity.html?oppId=296495
From U.S. Department of Health and Human Services, Office of Minority Health FYI Weekly Health Resources email, 8/16/17icon 
Subject(s) health promotion/wellness, mental health, minority health

Chronic Kidney Disease in Children Central Biochemistry Laboratory (U24): RFA-DK-17-034
SOURCE: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
APPLICATION DEADLINE: Letter of Intent: 10/3/17. Application: 11/3/17 by 5 pm local time of applicant organization.
$ AVAILABLE: The NIDDK intends to commit $325,000 in FY 2018 to fund one award.
ELIGIBILITY: * Public/state/private controlled institutions of higher education.
* Hispanic-serving institutions.
* Historically Black Colleges and Universities (HBCUs).
* Tribally Controlled Colleges and Universities (TCCUs).
* Alaska native and native Hawaiian serving institutions.
* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
* Small businesses.
* For-profit organizations (other than small businesses).
* State governments.
* County governments.
* City or township governments.
* Special district governments.
* Indian/Native American tribal governments (federally recognized and other than federally recognized).
* Eligible agencies of the federal government.
* Faith-based or community-based organizations.
* Regional organizations.
PURPOSE: The NIDDK invites Cooperative Agreement applications for an open competition for the Central Biochemistry Laboratory (CBL) of The Chronic Kidney Disease in Children (CKiD) consortium. The CBL will work cooperatively with the existing Clinical Coordinating Centers (CCCs) and Data Coordinating Center (DCC) of the study as a Consortium. Participant evaluations in some domains will be expanded, and follow-up will extend beyond the onset of End Stage Renal Disease (ESRD). 
CFDA: 93.847
CONTACT: Please see URL for multiple contacts. For more information see https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-17-034.html
From U.S. Department of Health and Human Services, Office of Minority Health FYI Weekly Health Resources email, 8/16/17icon 
Subject(s) health policy research, medical research
 
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R01): PA-17-444
SOURCE: National Human Genome Research Institute (NHGRI), National Cancer Institute (NCI), National Institute on Aging (NIA), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Deafness and Other Communication Disorders (NIDCD), National Institute of Environmental Health Sciences (NIEHS), National Institute of Neurological Disorders and Stroke (NINDS), National Institute on Minority Health and Health Disparities (NIMHD)
APPLICATION DEADLINE: 2/5, 6/5, 10/5 by 5 pm local time of applicant organization. Expires 9/8/20.
$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
ELIGIBILITY: * Public/state/private controlled institutions of higher education.
* Hispanic-serving institutions.
* Historically Black Colleges and Universities (HBCUs).
* Tribally Controlled Colleges and Universities (TCCUs).
* Alaska native and native Hawaiian serving institutions.
* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
* Small businesses.
* For-profit organizations (other than small businesses).
* State governments.
* County governments.
* City or township governments.
* Special district governments.
* Indian/Native American tribal governments (federally recognized and other than federally recognized).
* Eligible agencies of the federal government.
* U.S. territories or possessions.
* Independent school districts.
* Public housing authorities/Indian housing authorities.
* Native American tribal organizations (other than federally recognized tribal governments).
* Faith-based or community-based organizations.
* Regional organizations.
* Non-domestic (non-U.S.) entities (foreign institutions).
PURPOSE: This Funding Opportunity Announcement (FOA) invites Research Project Grant (R01) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. Applications may propose studies using either single or mixed methods. 
CFDA: 93.172, 93.399, 93.307, 93.173, 93.853, 93.866, 93.113, 93.865 
CONTACT: Please see URL for multiple contacts. For more information see https://grants.nih.gov/grants/guide/pa-files/PA-17-444.html
From NIH web site, accessed 8/18/17icon 
Subject(s) medical research
 
Ethical, Legal, and Social Implications (ELSI) of Genomics Research Project Grant Program (R03): PA-17-445
SOURCE: National Human Genome Research Institute (NHGRI), National Cancer Institute (NCI), National Institute on Aging (NIA), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Deafness and Other Communication Disorders (NIDCD), National Institute of Environmental Health Sciences (NIEHS), National Institute of Neurological Disorders and Stroke (NINDS), National Institute on Minority Health and Health Disparities (NIMHD)
APPLICATION DEADLINE: 3/16, 7/16, 11/16 by 5 pm local time of applicant organization. Expires 9/8/20.
$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
ELIGIBILITY: * Public/state/private controlled institutions of higher education.
* Hispanic-serving institutions.
* Historically Black Colleges and Universities (HBCUs).
* Tribally Controlled Colleges and Universities (TCCUs).
* Alaska native and native Hawaiian serving institutions.
* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
* Small businesses.
* For-profit organizations (other than small businesses).
* State governments.
* County governments.
* City or township governments.
* Special district governments.
* Indian/Native American tribal governments (federally recognized and other than federally recognized).
* Eligible agencies of the federal government.
* U.S. territories or possessions.
* Independent school districts.
* Public housing authorities/Indian housing authorities.
* Native American tribal organizations (other than federally recognized tribal governments).
* Faith-based or community-based organizations.
* Regional organizations.
* Non-domestic (non-U.S.) entities (foreign institutions).
PURPOSE: This Funding Opportunity Announcement (FOA) invites Small Research Grant (R03) applications to study the ethical, legal and social implications (ELSI) of human genome research. These applications should be for small, self-contained research projects, such as those that involve single investigators. Of particular interest are projects that propose normative or conceptual analyses, including focused legal, economic, philosophical, anthropological, or historical analyses of new or emerging issues. This mechanism can also be used for the collection of preliminary data and the secondary analysis of existing data.
CFDA: 93.172, 93.399, 93.307, 93.173, 93.853, 93.866, 93.113, 93.865 
CONTACT: Please see URL for multiple contacts. For more information see https://grants.nih.gov/grants/guide/pa-files/PA-17-445.html
From U.S. Department of Health and Human Services, Office of Minority Health FYI Weekly Health Resources email, 8/16/17icon 
Subject(s) health policy research, medical research
 
Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21): PA-17-446
SOURCE: National Human Genome Research Institute (NHGRI), National Cancer Institute (NCI), National Institute on Aging (NIA), Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Deafness and Other Communication Disorders (NIDCD), National Institute of Environmental Health Sciences (NIEHS), National Institute of Neurological Disorders and Stroke (NINDS), National Institute on Minority Health and Health Disparities (NIMHD)
APPLICATION DEADLINE: 2/16, 6/16, 10/16 by 5 pm local time of applicant organization. Expires 9/8/20.
$ AVAILABLE: The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.
ELIGIBILITY: * Public/state/private controlled institutions of higher education.
* Hispanic-serving institutions.
* Historically Black Colleges and Universities (HBCUs).
* Tribally Controlled Colleges and Universities (TCCUs).
* Alaska native and native Hawaiian serving institutions.
* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
* Small businesses.
* For-profit organizations (other than small businesses).
* State governments.
* County governments.
* City or township governments.
* Special district governments.
* Indian/Native American tribal governments (federally recognized and other than federally recognized).
* Eligible agencies of the federal government.
* U.S. territories or possessions.
* Independent school districts.
* Public housing authorities/Indian housing authorities.
* Native American tribal organizations (other than federally recognized tribal governments).
* Faith-based or community-based organizations.
* Regional organizations.
* Non-domestic (non-U.S.) entities (foreign institutions).
PURPOSE: This Funding Opportunity Announcement (FOA) invites Exploratory/Developmental Research Grant (R21) applications that propose to study the ethical, legal and social implications (ELSI) of human genome research. These applications should propose single or mixed methods studies that break new ground, extend previous discoveries in new directions or develop preliminary data in preparation for larger studies. Of particular interest are studies that explore the implications of new or emerging genomic technologies or novel uses of genomic information.
CFDA: 93.172, 93.399, 93.855, 93.307, 93.173, 93.853, 93.866, 93.113, 93.865 
CONTACT: Please see URL for multiple contacts. For more information see https://grants.nih.gov/grants/guide/pa-files/PA-17-446.html
From U.S. Department of Health and Human Services, Office of Minority Health FYI Weekly Health Resources email, 8/16/17icon 
Subject(s) health policy research, medical research

HIV-Associated Neuropathic Pain and Opioid Interaction (R01)
SOURCE: National Institute on Drug Abuse (NIDA)
APPLICATION DEADLINE: Letter of Intent: 11/18/17. Application: 12/18/17 by 5 pm local time of applicant organization.
$ AVAILABLE: NIDA intends to fund an estimate of four to five grant awards, corresponding to a total of $3 million for fiscal year 2018. Future year amounts will depend on annual appropriations.
ELIGIBILITY: * Public/state/private controlled institutions of higher education.
* Hispanic-serving institutions.
* Historically Black Colleges and Universities (HBCUs).
* Tribally Controlled Colleges and Universities (TCCUs).
* Alaska native and native Hawaiian serving institutions.
* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
* Small businesses.
* For-profit organizations (other than small businesses).
* State governments.
* County governments.
* City or township governments.
* Special district governments.
* Indian/Native American tribal governments (federally recognized and other than federally recognized).
* Eligible agencies of the federal government.
* U.S. territories or possessions.
* Independent school districts.
* Public housing authorities/Indian housing authorities.
* Native American tribal organizations (other than federally recognized tribal governments).
* Faith-based or community-based organizations.
* Regional organizations.
* Non-domestic (non-U.S.) entities (foreign institutions).
PURPOSE: The purpose of this RFA is to promote research investigating the underlying mechanisms by which opioids including prescription drugs exacerbate HIV-associated neuropathic pain. Results from these studies may help obtain information for developing safe and effective treatments of neuropathic pain for HIV-infected patients exposed to opioids. 
CFDA: 93.279
CONTACT: Please see URL for multiple contacts. For more information see https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-015.html
From NIH web site, accessed 8/18/17icon 
Subject(s) HIV/AIDS research, medical research

Pharmacogenomics of Anti-Retroviral Therapy in People Who Inject Drugs (R01): RFA-DA-18-014
SOURCE: National Institute on Drug Abuse (NIDA)
APPLICATION DEADLINE: Letter of Intent: 11/14/17. Application: 12/14/17 by 5 pm local time of applicant organization.
$ AVAILABLE: NIDA intends to fund an estimate of one to two awards, corresponding to a total of $3 million for fiscal year 2018. Future year amounts will depend on annual appropriations.
ELIGIBILITY: * Public/state/private controlled institutions of higher education.
* Hispanic-serving institutions.
* Historically Black Colleges and Universities (HBCUs).
* Tribally Controlled Colleges and Universities (TCCUs).
* Alaska native and native Hawaiian serving institutions.
* Asian American Native American Pacific Islander Serving Institutions (AANAPISIs).
* Nonprofits with or without 501(c)(3) IRS status (other than institutions of higher education).
* Small businesses.
* For-profit organizations (other than small businesses).
* State governments.
* County governments.
* City or township governments.
* Special district governments.
* Indian/Native American tribal governments (federally recognized and other than federally recognized).
* Eligible agencies of the federal government.
* U.S. territories or possessions.
* Independent school districts.
* Public housing authorities/Indian housing authorities.
* Native American tribal organizations (other than federally recognized tribal governments).
* Faith-based or community-based organizations.
* Regional organizations.
* Non-domestic (non-U.S.) entities (foreign institutions).
PURPOSE: The purpose of this funding opportunity is to identify genetic and epigenetic factors that affect the recovery of the CD4+ T cells in response to anti-retroviral therapy in HIV infected people who inject drugs infected.
CFDA: 93.279
CONTACT: Please see URL for multiple contacts. For more information see https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-18-014.html
From NIH web site, accessed 8/18/17icon 
Subject(s) HIV/AIDS research, medical research, substance abuse research

Strengthen the Evidence for Maternal and Child Health Programs: HRSA-18-077
SOURCE: Health Resources and Services Administration (HRSA)
APPLICATION DEADLINE: 10/10/17.
$ AVAILABLE: $700,000 for one award.
ELIGIBILITY: Any public or private entity, including an Indian tribe or tribal organization (as those terms are defied at 25 U.S.C. 450b), is eligible to apply for this federal funding opportunity. Faith-based and community-based organizations are also eligible to apply for these funds.
PURPOSE: This notice solicits applications for Strengthen the Evidence for Maternal and Child Health Programs, the purpose of which is to improve the health and well-being of women and children in the United States by supporting the implementation of evidence-based/evidence-informed strategies for the Title V Maternal and Child Health (MCH) Services Block Grant program (hereafter referred to as Title V MCH Block Grant). 
CFDA: 93.110
CONTACT: Sylvia Sosa, (301) 443-2259, email: ssosa@hrsa.gov. For more information see https://www.grants.gov/web/grants/view-opportunity.html?oppId=295210
From Health Resources and Services Administration email, 8/16/17icon
Subject(s) children's health, health promotion/wellness, women's health

Technical Assistance Support for the Strengthening of Blood Transfusion Services to Decrease HIV and Other Transfusion Transmitted Infections in Selected Countries under the President's Emergency Plan for AIDS Relief (PEPFAR): CDC-RFA-GH18-1814
SOURCE: Centers for Disease Control and Prevention (CDC)
APPLICATION DEADLINE: 10/15/17.
$ AVAILABLE: $1,270,000 for two awards.
ELIGIBILITY: Unrestricted.
PURPOSE: The purpose of this announcement is to strengthen the prevention of HIV transmission by ensuring that services provided by National Blood Transfusion Services (NBTS) in selected countries meet global standards for quality and safety including behavioral screening; blood collection from regular voluntary non-remunerated low risk blood donors; quality blood processing and testing for transfusion transmissible infections; blood component production, appropriate clinical use of blood, and haemovigilance testing, and quality, and by increasing the capacity to ensure adequate referral and tracing of blood donors with HIV reactive results to HTC programs for prevention counseling, confirmatory testing, and treatment services.
CFDA: 93.067
CONTACT: Please see URL for contact information. For more information see https://www.grants.gov/web/grants/search-grants.html?keywords=CDC-RFA-GH18-1814
From CDC National Prevention Information Network's (NPIN) HIV/Hepatitis/STD/TB Funding Information email, 8/17/17icon
Subject(s) HIV/AIDS education/prevention, HIV/AIDS services


Private Funding Opportunities

American Kidney Fund Invites Applications for 2018 Nephrology Program
SOURCE: American Kidney Fund 
APPLICATION DEADLINE: 11/20/17.
$ AVAILABLE: Fellowships may be granted yearly, with a maximum duration of two years for each fellowship and a maximum funding level of $80,000 per year.
ELIGIBILITY: To be eligible, applicants must have completed a residency in internal medicine or pediatric medicine; be qualified to sit for the American Board of Internal Medicine or Pediatric Medicine; be in the process of completing or have completed at least one year of training in clinical nephrology in an accredited U.S. program; demonstrate an aptitude for and a commitment to developing special expertise in an area of knowledge applicable to clinical nephrology; and intend to pursue a professional career with emphasis on the provision of care to patients with kidney disease.
PURPOSE: The American Kidney Fund provides charitable assistance to dialysis patients who need help with the costs associated with treating kidney failure. As part of this mission, the fund is accepting applications for its Clinical Scientist in Nephrology fellowship program.
The annual program was established in 1988 as a direct extension of AKF's mission to improve the quality of care of patients with kidney disease and to promote clinical research in nephrology. This goal is achieved by enhancing the training and education of nephrologists who wish to pursue an academic career and whose primary professional commitment is to scholarship in the provision of patient care. 
CONTACT: Please see URL for contact information. For more information see http://www.kidneyfund.org/training/clinical-scientist-in-nephrology/?referrer=http://philanthropynewsdigest.org/rfps/rfp7989-american-kidney-fund-invites-applications-for-2018-nephrology-program
From The Foundation Center's Philanthropy News Digest web site, accessed 8/17/17icon
Subject(s) medical research

American Psychological Foundation Accepting Applications for Weiss Research and Program Innovation Grants
SOURCE: American Psychological Foundation (APF)
APPLICATION DEADLINE: 9/15/17.
$ AVAILABLE: Grants of up $1,000.
ELIGIBILITY: To be eligible, applicants must be a graduate student or early-career researcher (no more than ten years postdoctoral); be affiliated with a nonprofit charitable, educational or scientific institution, or governmental entity operating exclusively for charitable and educational purposes; and have demonstrated competence and the capacity to execute the proposed work.
PURPOSE: The American Psychological Foundation is accepting applications for its APF Drs. Rosalee G. and Raymond A. Weiss Research and Program Innovation Grants program, which seek to seed innovation in the field by supporting research, education, and intervention projects and programs that use psychology to address social problems.
To that end, grants will be awarded for projects that foster connections between behavior and physical health to ensure well-being; reduce stigma and prejudice to promote unity and harmony; prevent violence to create a safer, more humane world; and support programs that address the long-term psychological needs of individuals and communities in the aftermath of disaster.
CONTACT: Please see URL for contact information. For more information see http://www.apa.org/apf/funding/weiss.aspx
From The Foundation Center's Philanthropy News Digest web site, accessed 8/17/17icon
Subject(s) medical research

American Urological Association Accepting Applications for 2018 Gallagher Health Policy Scholar Program
SOURCE: American Urological Association (AUA)
APPLICATION DEADLINE: 10/13/17.
$ AVAILABLE: A stipend of $15,000 and reimbursement for travel and other expenses will be provided over the course of the year-long program.
ELIGIBILITY: To be eligible, applicants must be a member of AUA who has demonstrated a commitment to, or has a keen interest in, the field of health policy and who is dedicated to advancing urology-focused health policy agenda.
PURPOSE: The American Urological Association is accepting applications for its 2018 Gallagher Health Policy Scholar program.
The annual program is designed to support young urologists who have demonstrated a commitment to, or have a keen interest in, the field of health policy and who are dedicated to advancing AUA’s health policy agenda. Gallagher Scholars spend up to thirty days away from their practice in intensive workshops dedicated to a range of health policy issues. They also will receive mentoring from seasoned physician volunteers, invitations to important meetings and conferences, and opportunities to participate in public policy activities as outlined by the Public Policy Council.
CONTACT: Please see URL for contact information. For more information see https://www.auanet.org/advocacy/scholar-and-fellowship-programs/gallagher-health-policy-scholar-program
From The Foundation Center's Philanthropy News Digest web site, accessed 8/17/17icon
Subject(s) medical research

Childhood Arthritis and Rheumatology Research Alliance Accepting Applications for Large Grant Program
SOURCE: Childhood Arthritis and Rheumatology Research Alliance (CARAA)
APPLICATION DEADLINE: Letters of Intent: 9/1/17.
$ AVAILABLE: Between one and five grants of up $50,000.
ELIGIBILITY: New or early investigators are encouraged to apply and will be afforded special consideration. Priority will be given to current CARRA members in good standing.
PURPOSE: The Childhood Arthritis and Rheumatology Research Alliance is accepting Letters of Intent for its annual CARRA Large Grant program.
In 2017, grants will be awarded to support the development and publication of a clinical or translational project that will immediately impact research projects within CARRA, or result in a larger collaborative grant that furthers the CARRA mission.
CONTACT: Please see URL for contact information. For more information see https://carragroup.org/members/grants-and-funding/#lgrant
From The Foundation Center's Philanthropy News Digest web site, accessed 8/18/17icon
Subject(s) medical research


Events

Association of Nurses in AIDS Care 2017 Conference
SPONSOR: Association of Nurses in AIDS Care
WHEN: November 2-4.
WHERE: The Fairmont Dallas, 1717 North Akard Street, (Dallas, TX).
DESCRIPTION: ANAC2017 is the leading conference for nurse practitioners and nurses working in HIV and its associated conditions, co-infections and co-morbidities. ANAC2017 includes expert speakers, symposia, roundtable discussions and abstract-driven presentations.
COST: Please see https://www.nursesinaidscare.org/i4a/pages/index.cfm?pageID=4705 for fee information and registration.
CONTACT: Association of Nurses in AIDS Care, (800) 260-6780, email: anac@anacnet.org
From DSHS HIV/STD program HIV/STD Insider email, 8/18/17icon

Competencies of Contemporary Leaders 
SPONSOR: Center for Nonprofit Studies at Austin Community College 
WHEN: September 7, 9 am to 1 pm.
WHERE: ACC Highland Business Center, 5930 Middle Fiskville Road, (Austin, TX).
DESCRIPTION: In today’s business world, it’s no longer about “managing,” but rather about leading. And, yes, there is a huge distinction about the differences.
Instead of focusing on surface skills, we will go through a process of mastering the Seven Competencies of Contemporary Leadership. These Seven Competencies create a contemporary leader that is tuned in to the whole person and embraces overlooked ingredients such as feelings and passion. He is in touch with the needs of the business while also being a role model of balance, integrity, and concern for his team. Most of all, he is open and accountable to being all that he can be. 
COST: $35. For more information and to register go to http://sites.austincc.edu/npo/event-listing/competencies-of-contemporary-leaders/
CONTACT: Kate Tolliver, (512) 223-7080, email: katelyn.tolliver@austincc.edu.
From Center for Nonprofit Studies at Austin Community College web site, accessed 8/18/17icon

Effective Grant Writing
SPONSOR: Center for Nonprofit Studies at Austin Community College 
WHEN: September 28, 9 am to 4 pm.
WHERE: ACC Highland Business Center, 5930 Middle Fiskville Road, (Austin, TX).
DESCRIPTION: A one-day complete “nuts and bolts” guide to grant proposal development and management of critical proposal development processes. Participants will develop a detailed outline of a full grant proposal and develop logical and compelling narrative and spreadsheets in the challenging sections of needs assessments, objectives, evaluation and budget. Participants will also develop strategies for researching, cultivating, communicating, and building partnerships with foundation, corporation, and government funders.
Additionally, the workshop will cover “important yet rarely-discussed” topics such as writing and editing styles, expectations and measurement of a successful grant writing program, the relationship of grants to overall organizational fundraising, the role of management and volunteer leadership in grant-development initiatives, and organizational team-building to support grant proposal development. Comprehensive handouts and online resources are provided.
This workshop has been highly rated as effective for both the beginner and advanced grant-writer, because of the unique perspectives provided by the presenter.
COST: $99. For more information and to register go to http://sites.austincc.edu/npo/event-listing/effective-grant-writing-3/
CONTACT: Kate Tolliver, (512) 223-7080, email: katelyn.tolliver@austincc.edu.
From Center for Nonprofit Studies at Austin Community College web site, accessed 8/18/17icon


returnReturn to Alert

Last updated August 22, 2017